Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma

被引:1
|
作者
Dehbidi, Sahar [1 ]
Farokhizadeh, Zhaleh [1 ]
Karimi, Mohammad Hossein [2 ]
Afshari, Afsoon [2 ]
Behmanesh, Mehrdad [3 ]
Sanati, Mohammad Hossein [4 ]
Geramizadeh, Bita [2 ]
Yaghobi, Ramin [2 ]
机构
[1] Nour Danesh Inst Higher Educ, Fac Biol Sci, Dept Biol, Esfahan, Iran
[2] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran
[3] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[4] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran
关键词
Hepatocellular Carcinoma; MicroRNA; Liver Transplantation; Rejection; Polymorphism; TURKISH POPULATION; FUNCTIONAL POLYMORPHISM; EXPRESSION PATTERNS; HUMAN CANCER; ASSOCIATION; RISK; INFECTION; SUSCEPTIBILITY; MIR-499A-GREATER-THAN-G; CONTRIBUTES;
D O I
10.5812/hepatmon.102690
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic polymorphism in the miRNA sequence might alter miRNA expression and/or maturation, which is associated with the development and progression of hepatocellular carcinoma (HCC) in liver transplant patients. Objectives: Therefore, the prevalence of miRNA-146a G > C (rs2910164), miRNA-499A > G (rs3746444), miRNA-149C > T (rs2292832), and miRNA-196a-2 C > T (rs11614913) gene polymorphisms was evaluated in liver recipients with HCC with or without experiencing graft rejection. Methods: In a cross-sectional study, tissue samples were collected from 60 HCC patients who underwent liver transplant surgery at Namazi Hospital, Shiraz, Iran, in 2013 - 2015. A control group consisting of 120 individuals was randomly selected, as well. The genomic DNA was extracted from collected tissues and blood samples. The miRNA-146a (rs2910164), miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) gene polymorphisms were evaluated in patients with HCC using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism were significantly associated with the increased risk of transplant rejection in patients with HCC (P = 0.05 and P = 0.05, respectively). The CC genotype and C allele of the miRNA-146a (rs2910164) were also significantly more frequent in male liver transplant patients who experienced acute rejection than in non-rejected ones (P = 0.05 and P = 0.03, respectively). However, no significant association was found between the genotypes and alleles of miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) polymorphisms and HCC outcomes in liver transplant recipients. Conclusions: The importance of the CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism in increasing the risk of transplant rejection was confirmed, but it needs further studies in larger populations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma
    Afshari, Afsoon
    Yaghobi, Ramin
    Karimi, Mohammad Hossein
    Mowla, Javad
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [2] Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma
    Afsoon Afshari
    Ramin Yaghobi
    Mohammad Hossein Karimi
    Javad Mowla
    BMC Gastroenterology, 21
  • [3] microRNA Analysis, of Hepatocellular Carcinoma Recurrence after Liver Transplant
    Barry, C. T.
    D'Souza, M.
    Ryan, C.
    Safadjou, S.
    Kashyap, R.
    Marroquin, C.
    Orloff, M.
    Almudevar, A.
    Godfrey, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 129 - 129
  • [4] LIVER TRANSPLANT ALLOCATION TO PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Dawwas, Muhammad F.
    Watson, Christopher J.
    Gimson, Alexander E.
    HEPATOLOGY, 2008, 48 (04) : 351A - 351A
  • [5] Access to Liver Transplant Referral, Evaluation, and Listing for Hepatocellular Carcinoma Patients in Georgia
    Ross-Driscoll, K.
    Ayuk-Arrey, A.
    Lynch, R.
    McCullough, L. E.
    Roccaro, G.
    Patzer, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S729 - S729
  • [6] Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
    Yadav, Dipesh Kumar
    Chen, Wei
    Bai, Xueli
    Singh, Alina
    Li, Guogang
    Ma, Tao
    Yu, Xiazhen
    Xiao, Zhi
    Huang, Bingfeng
    Liang, Tingbo
    ANNALS OF TRANSPLANTATION, 2018, 23 : 524 - 545
  • [7] MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma
    Chu, Yin-Hung
    Hsieh, Ming-Ju
    Chiou, Hui-Ling
    Liou, Yi-Sheng
    Yang, Chen-Chieh
    Yang, Shun-Fa
    Kuo, Wu-Hsien
    PLOS ONE, 2014, 9 (02):
  • [8] Changing opportunities for liver transplant for patients with hepatocellular carcinoma
    Zendel, Alex
    Watkins, Randall
    Moon, Andrew M.
    Gerber, David A.
    Barritt, A. Sidney
    Desai, Chirag S.
    CLINICAL TRANSPLANTATION, 2022, 36 (05)
  • [9] Management of liver transplant patients with recurrence of hepatocellular carcinoma
    Safak, Adem
    Karakaya, Emre
    Yildirim, Sedat
    Okyay, Ozan
    Boyvat, Fatih
    Tseveldorj, Nomingerel
    Boyacioglu, Sedat
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (09) : 648 - 648
  • [10] A New Liver Transplant Priority for Patients with Hepatocellular Carcinoma
    Ravaioli, Matteo
    Grazi, Gian Luca
    Vetrone, Gaetano
    Kimura, Takuya
    Zanello, Matteo
    Ercolani, Giorgio
    Cescon, Matteo
    Varotti, Giovanni
    Del Gaudio, Massimo
    Tuci, Francesco
    Cucchetti, Alessandro
    La Barba, Giuliano
    Vivarelli, Marco
    Lauro, Augusto
    Ramacciato, Giovanni
    Pinna, Antonio Daniele
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1742 - 1745